Search
DiaMedica Therapeutics Inc
DMACAdd to Watchlist
9.520USD
-0.300-3.05%
Close 10-29 16:00（ET）
513.41MMarket Cap
LossP/E TTM
Today
-3.05%
5 Days
+10.31%
1 Month
+16.10%
6 Months
+59.73%
Year to Date
+19.60%
1 Year
+42.30%
Key Figures
9.830Open
9.990High
21.09KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.04%Turnover Ratio
9.820Prev. Close
9.410Low
203.82KTurnover
LossP/E Static
13.42P/B
0.00%Div Yield TTM
-76.38%ROA
10.42052wk High
0.10Volume Ratio
-24.44MNet Profit
53.93MShares
-0.7042EPS TTM
0.97Beta
-86.47%ROE
5.24552wk Low
15.58%Amplitude
--Gross Margin
513.41MMarket Cap
-1.41Reward/Risk
3.69%Risk Rate
DiaMedica Therapeutics Inc's Score
-0.04vs previous score
Forecast8.00
Financial Health5.46
Technical5.01
Valuation Dimensions8.17
Institutional Confidence3.00
Risk Assessment4.67
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
DiaMedica Therapeutics Inc Technical Analysis
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.19/-0.20
Revenue / Forecast
--/0.00
DiaMedica Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolDMAC
Number of employees27
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Trill AB,LLC. | 16.38% |
| EQT Partners AB | 15.56% |
| Jacinto (Richard II) | 9.20% |
| Omega Advisors, Inc. | 3.75% |
| Shareholder Types | Proportion |
|---|---|
| Corporation | 16.38% |
| Private Equity | 15.56% |
| Individual Investor | 11.36% |
| Investment Advisor | 9.90% |
Related Instruments
+6.63%
+1.53%
+1.68%
+3.83%
+3.22%
+2.88%
+1.97%
+4.03%
+2.22%
+1.70%
+1.95%
+1.35%
+2.12%
+2.11%
-0.12%
+4.01%
+0.68%
-0.69%
+2.59%
+0.68%Popular Instruments
52363.000
+25.600 (+0.05%)
28834.100
-230.900 (-0.79%)
7654.400
-21.300 (-0.28%)
12800.000
-41.000 (-0.32%)
63249.000
-735.000 (-1.15%)
6180.200
-18.400 (-0.30%)
102.598
+0.196 (+0.19%)
348.910
+5.080 (+1.48%)
213.660
-1.720 (-0.80%)
3987.800
-33.150 (-0.82%)
FAQs
What is the current price of DiaMedica Therapeutics Inc (DMAC)?
The current price of DiaMedica Therapeutics Inc (DMAC) is 9.52.
What is the symbol of DiaMedica Therapeutics Inc?
The ticker symbol of DiaMedica Therapeutics Inc is DMAC.
What is the 52-week high of DiaMedica Therapeutics Inc?
The 52-week high of DiaMedica Therapeutics Inc is 10.42.
What is the 52-week low of DiaMedica Therapeutics Inc?
The 52-week low of DiaMedica Therapeutics Inc is 5.25.
What is the market capitalization of DiaMedica Therapeutics Inc?
The market capitalization of DiaMedica Therapeutics Inc is 513.41M.
Is DiaMedica Therapeutics Inc (DMAC) currently rated as Buy, Hold, or Sell?
According to analysts, DiaMedica Therapeutics Inc (DMAC) has an overall rating of Buy, with a price target of 17.00.
What is the Earnings Per Share (EPS TTM) of DiaMedica Therapeutics Inc (DMAC)?
The Earnings Per Share (EPS TTM) of DiaMedica Therapeutics Inc (DMAC) is -0.70.